Clinical Trial Update: Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]

View source ↗

Summary

This update reports a Phase 2 trial of flavopiridol in recurrent or persistent endometrial cancer, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED